CTSI strives to be a pioneering pediatric academic enterprise that enhances the health of children by fostering therapeutic discovery through collaborative clinical and translational research.
The CTSI Child Health Research area strives to:
- Conduct pediatric clinical and translational research to make evidence-based therapeutics available to children.
- Expand pediatric research training and mentoring for students, residents, pediatric fellows, and junior- and mid-career faculty, so they can become future leaders in pediatric clinical and translational research.
- Disseminate results of pediatric clinical and translational research through publications and meetings so that the care of children is improved through these study findings.
Resources available to investigators at Duke include:
- The Pediatric Neurocognitive Outcomes unit, supported by CTSI, offers investigators assistance in assessing various domains of neuropsychological function, behavioral/psychosocial functioning, and quality of life in children. For more information, contact Kathryn Gustafson, PhD.
- The Pediatric Trials Network is an alliance of clinical research sites located around the United States that are cooperating in the design and conduct of pediatric clinical trials to improve health care for the youngest patients. The PTN is studying the formulation, dosing, efficacy, and safety of drugs, as well as the development of medical devices, used in pediatric patients. Danny Benjamin, MD, a faculty member of the DCRI, is the principal investigator for the Pediatric Trials Network, which is centered at Duke.
Co-Investigator, CTSA Grant; Professor of Pediatrics
Director, Pediatric Neurocognitive Outcomes Program